From treatment to organ damage; A 5‐year follow‐up study of ambulatory blood pressure in essential hypertension. Diversity between development of left ventricular hypertrophy and urinary albumin excretion

References

• Koren M. J., Devereux R. B., Casale P. N., Savage D. D., Laragh J. H. Relation of left ventricular mass and geometry to morbidity and mortality in uncomplicated essential hypertension. Ann Intern Med 1991; 114: 345–352
   PubMed Web of Science ®Google Scholar
• Schillaci G., Verdecchia P., Porcellati C., Cuccurullo O., Cosco C., Perticone F. Continuous relation between left ventricular mass and cardiovascular risk in essential hypertension. Hypertension 2000; 35: 580–586
   PubMed Web of Science ®Google Scholar
• Clement D. L., De Buyzere M. L., De Bacquer D. A., de Leeuw P. W., Duprez D. A., Fagard R. H., et al. Prognostic value of ambulatory blood‐pressure recordings in patients with treated hypertension. N Engl J Med 2003; 348: 2407–2415
   PubMed Web of Science ®Google Scholar
• Staessen J. A., Thijs L., Fagard R., O'Brien E. T., Clement D., de Leeuw P. W., et al. Predicting cardiovascular risk using conventional vs ambulatory blood pressure in older patients with systolic hypertension. Systolic Hypertension in Europe Trial Investigators. JAMA 1999; 282: 539–546
   PubMed Web of Science ®Google Scholar
• Bulatov V. A., Stenehjem A., Os I. Left ventricular mass assessed by electrocardiography and albumin excretion rate as a continuum in untreated essential hypertension. J Hypertens 2001; 19: 1473–1478
   PubMed Web of Science ®Google Scholar
• Kario K., Matsuo T., Kobayashi H., Imiya M., Matsuo M., Shimada K. Nocturnal fall of blood pressure and silent cerebrovascular damage in elderly hypertensive patients. Advanced silent cerebrovascular damage in extreme dippers. Hypertension 1996; 27: 130–135
   PubMed Web of Science ®Google Scholar
• Verdecchia P., Porcellati C., Schillaci G., Borgioni C., Ciucci A., Battistelli M., et al. Ambulatory blood pressure. An independent predictor of prognosis in essential hypertension. Hypertension 1994; 24: 793–801
   PubMed Web of Science ®Google Scholar
• Parati G., Omboni S., Rizzoni D., Gabiti‐Rosei E., Mancia G. The smoothness index: A new, reproducible and clinically relevant measure of the homogeneity of the blood pressure reduction with treatment for hypertension. J Hypertens 1998; 16: 1685–1691
   PubMed Web of Science ®Google Scholar
• Rizzoni D., Muiesan M. L., Salvetti M., Castellano M., Bettoni G., Monteduro C., et al. The smoothness index, but not the trough‐to‐peak ratio predicts changes in carotid artery wall thickness during antihypertensive treatment. J Hypertens 2001; 19: 703–711
   PubMed Web of Science ®Google Scholar
• Boulatov V. A., Stenehjem A., Os I. Association between albumin:creatinine ratio and 24‐hour ambulatory blood pressure in essential hypertension. Am J Hypertens 2001; 14: 338–344
   PubMed Web of Science ®Google Scholar
• Romundstad S., Holmen J., Hallan H., Kvenild K., Kruger O., Midthjell K. Microalbuminuria, cardiovascular disease and risk factors in a nondiabetic/nonhypertensive population. The Nord‐Trondelag Health Study (HUNT, 1995–97), Norway. J Intern Med 2002; 252: 164–172
   PubMed Web of Science ®Google Scholar
• Ibsen H., Olsen M. H., Wachtell K., Borch‐Johnsen K., Lindholm L. H., Mogensen C. E., et al. Reduction in albuminuria translates to reduction in cardiovascular events in hypertensive patients: Losartan intervention for endpoint reduction in hypertension study. Hypertension 2005; 45: 198–202
   PubMed Web of Science ®Google Scholar
• Stenehjem A. E., Os I. Reproducibility of blood pressure variability, white‐coat effect and dipping pattern in untreated, uncomplicated and newly diagnosed essential hypertension. Blood Press 2004; 13: 214–224
   PubMed Web of Science ®Google Scholar
• Stenehjem A. E., Os I. Clinical utility and applicability of smoothness index, normalized smoothness index and individualized RDH index during treatment of essential hypertension. Blood Press 2006; 15: 281–290
   PubMed Web of Science ®Google Scholar
• O'Brien E., Waeber B., Parati G., Staessen J., Myers M. G. Blood pressure measuring devices: Recommendations of the European Society of Hypertension. BMJ 2001; 322: 531–536
   PubMed Web of Science ®Google Scholar
• Modesti P. A., Costoli A., Cecioni I, I., Toccafondi S., Carnemolla A., Serneri G. G. Clinical evaluation of the QuietTrak blood pressure recorder according to the protocol of the British Hypertension Society. Blood Press Monit 1996; 1: 63–68
   PubMedGoogle Scholar
• European Society of Hypertension‐European Society of Cardiology guidelines for the management of arterial hypertension. J Hypertens 2003; 21: 1011–1053
   PubMed Web of Science ®Google Scholar
• Devereux R. B., Alonso D. R., Lutas E. M., Gottlieb G. J., Campo E., Sachs I., et al. Echocardiographic assessment of left ventricular hypertrophy: Comparison to necropsy findings. Am J Cardiol 1986; 57: 450–458
   PubMed Web of Science ®Google Scholar
• Devereux R. B., Lutas E. M., Casale P. N., Kligfield P., Eisenberg R. R., Hammond I. W., et al. Standardization of M‐mode echocardiographic left ventricular anatomic measurements. J Am Coll Cardiol 1984; 4: 1222–1230
   PubMed Web of Science ®Google Scholar
• Ganau A., Devereux R. B., Roman M. J., de S. G., Pickering T. G., Saba P. S., et al. Patterns of left ventricular hypertrophy and geometric remodeling in essential hypertension. J Am Coll Cardiol 1992; 19: 1550–1558
   PubMed Web of Science ®Google Scholar
• Wachtell K., Olsen M. H., Dahlof B., Devereux R. B., Kjeldsen S. E., Nieminen M. S., et al. Microalbuminuria in hypertensive patients with electrocardiographic left ventricular hypertrophy: The LIFE study. J Hypertens 2002; 20: 405–412
   PubMed Web of Science ®Google Scholar
• Koren M. J., Ulin R. J., Koren A. T., Laragh J. H., Devereux R. B. Left ventricular mass change during treatment and outcome in patients with essential hypertension. Am J Hypertens 2002; 15: 1021–1028
   PubMed Web of Science ®Google Scholar
• Mancia G., Carugo S., Grassi G., Lanzarotti A., Schiavina R., Cesana G., et al. Prevalence of left ventricular hypertrophy in hypertensive patients without and with blood pressure control: Data from the PAMELA population. Pressioni Arteriose Monitorate E Loro Associazioni. Hypertension 2002; 39: 744–749
   PubMed Web of Science ®Google Scholar
• Strand A. H., Gudmundsdottir H., Os I., Smith G., Westheim A. S., Bjornerheim R., et al. Arterial plasma noradrenaline predicts left ventricular mass independently of blood pressure and body build in men who develop hypertension over 20 years. J Hypertens 2006; 24: 905–913
   PubMed Web of Science ®Google Scholar
• Abergel E., Tase M., Bohlender J., Menard J., Chatellier G. Which definition for echocardiographic left ventricular hypertrophy?. Am J Cardiol 1995; 75: 498–502
   PubMed Web of Science ®Google Scholar
• Molloy T. J., Okin P. M., Devereux R. B., Kligfield P. Electrocardiographic detection of left ventricular hypertrophy by the simple QRS voltage‐duration product. J Am Coll Cardiol 1992; 20: 1180–1186
   PubMed Web of Science ®Google Scholar
• Levy D., Labib S. B., Anderson K. M., Christiansen J. C., Kannel W. B., Castelli W. P. Determinants of sensitivity and specificity of electrocardiographic criteria for left ventricular hypertrophy. Circulation 1990; 81: 815–820
   PubMed Web of Science ®Google Scholar
• Tonstad S., Furu K., Rosvold E. O., Skurtveit S. Determinants of control of high blood pressure. The Oslo Health Study 2000–2001. Blood Press 2004; 13: 343–349
   PubMed Web of Science ®Google Scholar
• Westheim A., Klemetsrud T., Tretli S., Stokke H. P., Olsen H. Blood pressure levels in treated hypertensive patients in general practice in Norway. Blood Press 2001; 10: 37–42
   PubMed Web of Science ®Google Scholar
• Stenehjem A. E., Gudmundsdottir H., Os I. Office blood pressure measurements overestimate blood pressure control in renal transplant patients. Blood Press Moni 2006; 11: 125–133
   PubMed Web of Science ®Google Scholar